TABLE 4.
Activity of ciprofloxacin and gentamicin against cefepime-, imipenem- or meropenem-, and piperacillin-tazobactam-resistant Gram-negative bacteria associated with infectiona
| Antibiotic with resistance | No. of resistant isolates | No. of isolates (%) susceptible to: |
|
|---|---|---|---|
| Ciprofloxacin | Gentamicin | ||
| Cefepime | 126 | 23 (18.3) | 49 (38.9) |
| Imipenem or meropenem | 78 | 20 (25.6) | 34 (43.6) |
| Piperacillin-tazobactam | 155 | 56 (36.1) | 90 (58.1) |
a
Comparison of ciprofloxacin and gentamicin susceptibility for the resistant isolates.